AR and neoplasm: Molecular modeling validated stable AR binding of Capillarisin (supported by ΔEMMPBSA analysis), with multi-component synergy identified across 20 signaling axes (notably neuroactive ligand-receptor interactions) modulating tumor microenvironments.